| 000 | 01065 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250511215047.0 | ||
| 264 | 0 | _c19910307 | |
| 008 | 199103s 0 0 eng d | ||
| 022 | _a0090-8258 | ||
| 024 | 7 |
_a10.1016/0090-8258(91)90087-l _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBuller, R E | |
| 245 | 0 | 0 |
_aDoes intraperitoneal CA-125 reflect disease status? _h[electronic resource] |
| 260 |
_bGynecologic oncology _cJan 1991 |
||
| 300 |
_a66-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntigens, Tumor-Associated, Carbohydrate _xanalysis |
| 650 | 0 | 4 |
_aAscitic Fluid _xchemistry |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aOvarian Neoplasms _xblood |
| 650 | 0 | 4 |
_aPeritoneal Diseases _xdiagnosis |
| 650 | 0 | 4 | _aRadioimmunoassay |
| 700 | 1 | _aManetta, A | |
| 700 | 1 | _aBloss, J D | |
| 700 | 1 | _aDiSaia, P J | |
| 700 | 1 | _aBerman, M L | |
| 773 | 0 |
_tGynecologic oncology _gvol. 40 _gno. 1 _gp. 66-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0090-8258(91)90087-l _zAvailable from publisher's website |
| 999 |
_c1996101 _d1996101 |
||